Normal view MARC view ISBD view

Metastasis of Ewing's sarcoma to the choroid. [electronic resource]

By:

Jampol, L M

Contributor(s):

Producer: 19730504Description: 207-9 p. digitalISSN:

0003-9950

Subject(s):

Online resources:

Available from publisher's website

In: Archives of ophthalmology (Chicago, Ill. : 1960) vol. 89

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Multimodal imaging of acquired vitelliform lesion diagnosed at pseudohypopyon stage.
by Gonçalves, Nuno Moreira
2 Intravitreal bevacizumab for neovascular age-related macular degeneration with or without prior treatment with photodynamic therapy: one-year results.
by Carneiro, Angela M
3 Spectral-domain optical coherence tomography of the choroid during valsalva maneuver.
by Falcão, Manuel
4 Immediate effect of intravitreal injection of bevacizumab on intraocular pressure.
by Lemos-Reis, Ricardo
5 Open-globe injuries at an emergency department in Porto, Portugal: clinical features and prognostic factors.
by Teixeira, Sérgio M
6 Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
by Lemos Reis, Ricardo Filipe
7 Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting.
by Carneiro, Angela M
8 Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab.
by Carneiro, Angela M
9 Choroidal and macular thickness changes induced by cataract surgery.
by Falcão, Manuel S
10 Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.
by Carneiro, Angela M
11 Vascular endothelial growth factor plasma levels before and after treatment of neovascular age-related macular degeneration with bevacizumab or ranibizumab.
by Carneiro, Angela M